Directa-Directa-1-2026-Hrhd-1

Original title (Spanish): DIRECTA-DIRECTA-1-2026-HRHD-1

Gobierno Regional DE Arequipa-hospital Regional Honorio Delgado · Peru government procurement

GlobalGov surfaces government procurement from around the world, including the markets your competitors overlook.

$281,605
Est. Value
Active
Status

Opportunity Overview

Adquisición del Medicamento EMICIZUMAB 150 MG/ML INY 1 ML Y EMICIZUMAB 105 MG/0.7 ML INY 0.7 ML para pacientes con enfermedades raras, por procedimiento de selección no competitivo por proveedor único Ítems: EMICIZUMAB 105 MG/0.7 ML INY 0.7 ML | EMICIZUMAB 150 MG/ML INY 1 ML Método: Contratación Directa

Your competitors are watching the same crowded contracts everyone else is. Track this opportunity and every one like it worldwide, set deadline alerts, and win where they aren’t. Free for 14 days, no card.

Start Free

Solicitation Details

Issuing agencyGobierno Regional DE Arequipa-hospital Regional Honorio Delgado
CountryPeru
CategoryGovernment Procurement
Estimated value$281,605
PublishedMarch 27, 2026
Procurement stageRequest for Proposal (RFP)
Response dueNot specified / rolling
StatusOpen — accepting responses
TranslationTranslated from Spanish by GlobalGov’s translation pipeline
Official sourceView original notice
Last verifiedSeptember 22, 2026

Source: SEACE — OSCE/OECE Peru, open data licensed CC BY 4.0. Not affiliated with the Government of Peru.

Related Opportunities in Peru

DIRECTA-DIRECTA-6-2026-MINEDU/ UE 026.-1
LIVE-LIVE-3-2026-MPC/DEC-1

See every Peru Government Procurement opportunity your competition is missing. Free for 14 days.

Get real-time alerts, competitive intelligence, and deadline tracking for this and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required

See who is already competing here →

Get a free Peru Government Procurement intelligence report in your inbox

A personalized report on Peru Government Procurement opportunities, emailed in 5-10 minutes. One per month, no account needed.